本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cyclacel Pharmaceuticals

5.05
0.0000
成交量:- -
成交额:- -
市值:169.33万
市盈率:-125.44
高:5.05
开:5.05
低:5.05
收:5.05
52周最高:17.00
52周最低:3.29
股本:33.53万
流通股本:33.53万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.0403
每股收益(LYR):-33.4976
净资产收益率:-1950.23%
总资产收益率:-160.18%
市净率:0.55
市盈率(LYR):-0.15

数据加载中...

2021/12/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/25

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/12

重要事件披露

8-K/A [Amend] - Current report
2021/06/17

重要事件披露

8-K - Current report
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/12

重要事件披露

8-K - Current report
2021/03/24

重要事件披露

8-K - Current report
2021/03/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/15

重要事件披露

8-K - Current report
2021/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/24

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/15

重要事件披露

8-K - Current report
2021/01/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals